Literature DB >> 21710197

Current concepts in pacing 2010-2011: the right and wrong way to pace.

Simon Modi1, Andrew Krahn, Raymond Yee.   

Abstract

OPINION STATEMENT: Over five decades have passed since the first permanent cardiac pacemakers were introduced into clinical medicine. Evolving technology and falling costs have demanded adaptation to clinical practice and implantation trends and, with the advent of evidenced-based medicine, the specific roles and benefits of individual pacemaker technologies have never been so carefully scrutinized. Pacing mode choice continues to be a subject of great controversy, and there are great regional variations in practice. We believe that single chamber atrial pacing use (AAI/R) has become an anachronism that should generally be abandoned (obviously with rare exceptional cases) and be replaced by dual chamber pacemakers (DDD/R) equipped with modern pacing algorithms that minimize patient exposure to ventricular pacing. Also, in patients with atrioventricular (AV) block, randomized clinical trials have failed to show improvement in clinically relevant outcomes such as mortality, stroke, and heart failure, particularly in the elderly, which has led some to advocate that DDD/R devices should never be offered to elderly AV block patients. However, we believe that the elderly, like the young, come in many "shapes and sizes" and individualized medicine compels us to consider each pacemaker candidate as unique. Implanting DDD/R devices in chronologically older, yet physiologically younger, patients is justifiable and good medical practice. Where right ventricular (RV) pacing is necessary and unavoidable, physicians should consider routinely placing RV leads on the RV mid- or outflow tract septum because these location are as good, if not better, for patients than the current practice of RV apical lead placement. In patients with AV block and asymptomatic yet moderate to severely depressed left ventricular systolic function, primary cardiac resynchronization therapy (CRT) should be strongly considered. Compelling clinical trial evidence does not yet exist to indicate that CRT should be the standard of care in patients with AV block and intact left ventricular systolic function. Right ventricular septal lead placement remains a reasonable option.

Entities:  

Year:  2011        PMID: 21710197     DOI: 10.1007/s11936-011-0137-6

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  85 in total

1.  Selective site pacing: the future of cardiac pacing?

Authors:  Harry G Mond; Michael D Gammage
Journal:  Pacing Clin Electrophysiol       Date:  2004-06       Impact factor: 1.976

2.  Twenty four hour variation in plasma atrial natriuretic factor during VVI and DDD pacing.

Authors:  P E Vardas; M Markianos; E Skalidis; E Simantirakis; E Manios; E Papavasiliou
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

3.  Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.

Authors:  Panos E Vardas; Angelo Auricchio; Jean-Jacques Blanc; Jean-Claude Daubert; Helmut Drexler; Hugo Ector; Maurizio Gasparini; Cecilia Linde; Francisco Bello Morgado; Ali Oto; Richard Sutton; Maria Trusz-Gluza
Journal:  Eur Heart J       Date:  2007-08-28       Impact factor: 29.983

4.  Hemodynamic benefits of right ventricular outflow tract pacing: comparison with right ventricular apex pacing.

Authors:  C C de Cock; A Meyer; O Kamp; C A Visser
Journal:  Pacing Clin Electrophysiol       Date:  1998-03       Impact factor: 1.976

5.  Characterization of super-response to cardiac resynchronization therapy.

Authors:  John Rickard; Dharam J Kumbhani; Zoran Popovic; David Verhaert; Mahesh Manne; Daniel Sraow; Bryan Baranowski; David O Martin; Bruce D Lindsay; Richard A Grimm; Bruce L Wilkoff; Patrick Tchou
Journal:  Heart Rhythm       Date:  2010-04-08       Impact factor: 6.343

6.  Atrioventricular interval optimization in the right atrial appendage and interatrial septum pacing: a comparison between echo and peak endocardial acceleration measurements.

Authors:  L Padeletti; M C Porciani; P Ritter; A Michelucci; A Colella; P Pieragnoli; A Costoli; C Ciapetti; A Sabini; G Demarchi; L Gillio-Meina; G Gaggini; G F Gensini
Journal:  Pacing Clin Electrophysiol       Date:  2000-11       Impact factor: 1.976

7.  Pacemaker therapy in very elderly patients: long-term survival and prognostic parameters.

Authors:  Boris Schmidt; Michael Brunner; Manfred Olschewski; Christine Hummel; Thomas S Faber; Andreas Grom; Ulrich Giesler; Christoph Bode; Manfred Zehender
Journal:  Am Heart J       Date:  2003-11       Impact factor: 4.749

8.  Cost-effectiveness of dual-chamber pacemaker therapy: does single lead VDD pacing reduce treatment costs of atrioventricular block?

Authors:  U K Wiegand; J Potratz; F Bode; R Schreiber; H Bonnemeier; W Peters; H A Katus
Journal:  Eur Heart J       Date:  2001-01       Impact factor: 29.983

9.  Single chamber atrial pacing: an underused and cost-effective pacing modality in sinus node disease.

Authors:  K W Clarke; D T Connelly; R G Charles
Journal:  Heart       Date:  1998-10       Impact factor: 5.994

10.  Natural history of sinus node disease treated with atrial pacing in 213 patients: implications for selection of stimulation mode.

Authors:  J Brandt; H Anderson; T Fåhraeus; H Schüller
Journal:  J Am Coll Cardiol       Date:  1992-09       Impact factor: 24.094

View more
  2 in total

1.  Computational Optogenetics: A Novel Continuum Framework for the Photoelectrochemistry of Living Systems.

Authors:  Jonathan Wong; Oscar J Abilez; Ellen Kuhl
Journal:  J Mech Phys Solids       Date:  2012-06-01       Impact factor: 5.471

2.  Assessment of ventricular pacing in the setting of an institutional improvement program: insights into physiological pacing.

Authors:  Antoine Kossaify; Sylvana Zoghbi; Paul Milliez
Journal:  Clin Med Insights Cardiol       Date:  2012-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.